A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

Article Abstract:

A synthetic pentasaccharide named Org31540/SR90107A appears to be an effective anticoagulant for preventing deep vein thrombosis in patients who have had a hip replaced. Deep vein thrombosis occurs when a blood clot forms in the large veins of the leg.

Thrombosis, Deep vein, Deep vein thrombosis, Artificial hip joints, Hip prostheses, Complications

---

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery

Article Abstract:

The anticoagulant drug fondaparinux can lower the risk of thromboembolism during hip surgery by over 50% compared to enoxaparin, according to a study of 1711 patients. Thromboembolism is the formation of a blood clot in the legs that can travel to the lungs. It is common in patients who have surgery for a hip fracture.

Fractures (Injuries), Fractures, Hip joint, Hip fractures

---

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

Article Abstract:

The anticoagulant drug fondaparinux can lower the risk of thromboembolism during knee surgery by over 50% compared to enoxaparin. Thromboembolism is the formation of a blood clot in the legs, which can travel to the lungs. It is common during orthopedic surgery.

Knee

Similar abstracts:

• Abstracts: Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
• Abstracts: A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns
• Abstracts: Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies
• Abstracts: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Stem cell repopulation efficiency but not pool size is governed by p27(kip1)
• Abstracts: Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.